Stimuli-responsive mesoporous silica nanoparticles for cancer therapy: A review
The application of nanocarriers as selective drug delivery platforms, as imaging or as diagnostic agents has been evaluated in several studies in the area of biomedicine, namely for cancer therapy. Such systems have the potential to perform a controlled and site-specific delivery of therapeutic agen...
| Autor principal: | |
|---|---|
| Outros Autores: | , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2018
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.6/4687 |
| País: | Portugal |
| Oai: | oai:ubibliorum.ubi.pt:10400.6/4687 |